Check-cap reports first quarter 2023 financial results

Isfiya, israel , may 11, 2023 /prnewswire/ -- check-cap ltd. (the "company" or "check-cap") (nasdaq: chek), a clinical stage medical diagnostics company advancing the development of c-scan®, the first and only patient-friendly, preparation-free screening test to detect polyps before they may transform into colorectal cancer (crc), today announced financial results for the first quarter ended march 31, 2023.
CHEK Ratings Summary
CHEK Quant Ranking